KC

Konapala Chinmaya Deepak Patro

Active Director Director DIN 10880156
DIN 10880156 First appointment Dec 2024 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Konapala Chinmaya Deepak Patro

Data last updated:

Konapala Chinmaya Deepak Patro is a Director at Mednex Hospital Private Limited (since 2024). The company operates in Healthcare.

DIN 10880156
Primary Designation Director
Industry Healthcare
First Appointment 20 Dec 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mednex Hospital Private Limited U86100OD2024PTC047589
Director20 Dec 20242024Active

Board colleagues of Konapala Chinmaya Deepak Patro

Directorship timeline

Open interactive timeline →
Mednex Hospital Private Limited
Premium access

Shareholding and investment profile for Konapala Chinmaya Deepak Patro

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Konapala Chinmaya Deepak Patro

Konapala Chinmaya Deepak Patro currently holds 1 directorship: Mednex Hospital Private Limited (Director, since 20 Dec 2024).

Konapala Chinmaya Deepak Patro was first appointed on 20 Dec 2024 as Director at Mednex Hospital Private Limited.

The current boards of Konapala Chinmaya Deepak Patro's companies include Baryon Swain (Mednex Hospital Private Limited), Prakash Kumar Mohanty (Mednex Hospital Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available